Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Still Ahead of Its Fundamentals, Nio Shares Could Trend Lower

Sales could still grow year-over year. But, if it's not to the levels still factored into the NIO stock price, another move lower may be in the cards. Until we get a clearer picture of what's next, continue to avoid.

Buy the Pullback in Tortoise Acquisition II Ahead of Its Merger with Volta

More reasonably priced than other EV charging SPACs, the long-term potential of SNPR stock may outweigh the risk.

Even After the Sell-Off, Steer Clear of Palantir Stock

Add in the issues with insider selling, and the uncertainty it can hit its growth targets, and PLTR stock may have more room to fall from here. So, stay away.

7 Sin Stocks That You’re Better off To Just Say ‘No’

With these previously oversold sin stocks now overbought, what's the best move? It's time to quit them, cold turkey. Consider these seven sin stocks as names to sell into strength.

If You Have to Have CTRM Stock, Treat It Like the Huge Gamble It Is

In fact, with the potential for the recent round of stimulus to fuel more speculation, you may be able to take a gamble, and profit, from CTRM stock once again. However, if you choose to roll the dice, tread carefully.